From diseases to clinical candidates. Participants will explore new concepts in our understanding of disease mechanisms, both at the molecular level as well as systems biology levels, and discuss cutting edge approaches to best discover and design appropriate therapeutic modalities, from small molecules to biologics, cell-based therapies or gene-targeted approaches.
Meeting the challenges of optimal formulation design and manufacture. Participants will discuss how to meet the demands of individualized medicine and global health with cutting-edge formulation, bioanalytical technologies and manufacturing strategies.
From predictive experimental models to optimized clinical studies. Participants will discuss how scientific, technological and regulatory developments can increase success rate in clinical trials and help better individualize treatments, with new predictive experimental models and innovative methods for monitoring treatment exposure and response.
Developing context-appropriate solutions. Participants will learn how real-world evidence may contribute to address individual patient needs or important public health issues with the efficient implementation of therapeutic innovations in a context-appropriate manner in communities around the world.